All About Friedreich's Ataxia

Friedreich's Ataxia is one of the most common forms of Ataxia but is still a relatively rare disease. The National Ataxia Foundation is proud to host this webinar presented by Dr. David Lynch on March 6th, 2023. In "All About Friedreich's Ataxia", he gave an overview of the causes and symptoms of the disease, the typical diagnostic journey for those affected, and what to expect for clinical care.

For more on FA, register for our upcoming webinar on Friday, March 17 here: https://us02web.zoom.us/webinar/regis...

For more information on Ataxia, please visit our website: https://www.ataxia.org

Become a Free NAF member! https://bit.ly/JoinNAF

Follow us on Social Media!
NAF Facebook:   / ataxiafounda.  .
NAF Twitter:   / naf_ataxia  
NAF Instagram:   / ataxiafound.  .
Ataxia Subreddit:   / ataxia  

About the Speaker:

Dr. David Lynch obtained a BS in Molecular Biophysics and Biochemistry at Yale and an MD and PhD in Neuroscience at Johns Hopkins University. He maintains a dynamic program focused on the rare disease Friedreich's ataxia (FA). More specifically, the research led by Dr. Lynch spans clinical, translational, and basic science research efforts on FA that include conducting double-blind clinical trials, identifying biomarkers, and leading mechanistic studies in animal and cellular models of FA. The research conducted by Dr. Lynch and his lab team have led to a greater understanding of the metabolic dysfunction underlying FA. Their work has led to the creation of a patient database as well as a pipeline of more than 20 drug candidates that represent potential new therapies.

About the Series:

NAF is producing a series of monthly educational webinars that focus on one type of Ataxia at a time. Each month we will feature a different type. Clinical experts will join us to take a look at the causes and symptoms of the disease, the typical diagnostic journey for those affected, and what to expect for clinical care. Research experts will teach us how the disease is studied and give an overview of the current state of research and drug development.